Veritas In Silico (TSE:130A) EBITDA Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:130A Veritas In Silico Inc TSE:130A
11 GF Score
Price 円418.00
! 4 Warning Signs
View Full Analysis

What is Veritas In Silico EBITDA Margin %?

Veritas In Silico TSE:130A -3.91% 11 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:130A with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 940 Biotechnology companies, Veritas In Silico ranks worse than 73.51% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Veritas In Silico's EBITDA for the three months ended in Dec. 2025 was 円0.00 Mil. Veritas In Silico's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, Veritas In Silico's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Veritas In Silico  (TSE:130A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Veritas In Silico EBITDA Margin % Related Terms

Veritas In Silico EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Veritas In Silico's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico EBITDA Margin % Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
-366.55 -60.64 17.92 -101.36 -417.87

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -336.05 -515.20 0.00 0.00 -686.50

TSE:130A vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Veritas In Silico's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veritas In Silico EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's EBITDA Margin % falls into.


TSE:130A
11GF Score
Veritas In Silico Inc TSE:130A
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veritas In Silico EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Veritas In Silico's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-380.847/91.14
=-417.87 %

Veritas In Silico's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Veritas In Silico (TSE:130A) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Veritas In Silico and its competitors. According to the industry distribution chart, Veritas In Silico ranks #691 out of 940 companies in the Biotechnology industry, placing it in the top 73.5%.
Is Veritas In Silico's EBITDA Margin % too high?
Veritas In Silico's current EBITDA Margin % is 0.00%. Based on the distribution chart, Veritas In Silico ranks #691 out of 940 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Veritas In Silico has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Veritas In Silico's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Veritas In Silico ranks #691 out of 940 companies for EBITDA Margin %. This places Veritas In Silico in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Veritas In Silico and its competitors. Veritas In Silico's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veritas In Silico stock overvalued right now?
Veritas In Silico (TSE:130A) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Veritas In Silico's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Veritas In Silico (TSE:130A), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veritas In Silico Business Description

Address 1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
11GF Score

Get the complete analysis for TSE:130A

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円418.00
Price